Ex Parte KIKUCHI et al - Page 3



          Appeal No. 2003-2020                                                        
          Application No. 08/944,208                                                  

                                       OPINION                                        
               As a preliminary matter, we note that appellants indicate on           
          page 5 of the Brief that the claims "should not stand or fall               
          together."  However, appellants have presented separate arguments           
          in accordance with 37 C.F.R. § 1.192(c)(8) (which was in effect             
          at the time of the Brief) only for claim 15.  Therefore, we will            
          treat claims 3, 4, and 9 through 14 as one group, with claim 13             
          as representative, and we will treat claim 15 as a second group.            
               We have carefully considered the claims, the applied prior             
          art references, and the respective positions articulated by                 
          appellants and the examiner.  As a consequence of our review, we            
          will reverse both the enablement rejection and the obviousness              
          rejection of claim 15 and affirm the obviousness rejection of               
          claims 3, 4, and 9 through 14.                                              
               Regarding the enablement rejection of claim 15, the examiner           
          states (Final Rejection, page 2) that the claim language                    
          "consisting of" limits the antistatic polymer to the polyether              
          ester-amide recited in the claim.  On the other hand, the                   
          examiner asserts that the specification states that the                     
          antistatic polymer contains polyether ester-amide, which "means             
          that the anti-static polymer is not composed of merely polyether            

                                          3                                           




Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  Next 

Last modified: November 3, 2007